Patents by Inventor Dangsheng Li

Dangsheng Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200181605
    Abstract: A high-throughput protein analysis method includes: using a tagged semi-cloned mouse library to perform parallel indicator analysis on a plurality of different target proteins of interest with one or several tag protein antibodies. In the tagged semi-cloned mouse library, each semi-cloned mouse is a semi-cloned mouse obtained by culturing after injecting an androgenetic haploid embryonic stem cell into an ovum, or a sexually propagated progeny thereof, the androgenetic haploid embryonic stem cell contains a gene that expresses a fusion protein of a target protein of interest and a tag protein, and the semi-cloned mouse can express the fusion protein of the target protein of interest and the tag protein. The system is suitable for high-throughput in vivo, real-time and dynamic research for research on biomacromolecules.
    Type: Application
    Filed: October 31, 2019
    Publication date: June 11, 2020
    Applicant: SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES
    Inventors: Jinsong LI, Jing JIANG, Yun ZHAO, Lin LI, Dangsheng LI
  • Patent number: 7932362
    Abstract: Nucleic acids encoding NRIF3 are described. Polypeptides having amino acid sequences of NRIF3 proteins are also provided. A method is also provided for isolating and cloning NRIF3 cDNA. NRIF3 is useful in development/implementation of high throughput screens to identify novel thyroid hormone receptor (TR) and retinoid X receptor (RXR) agonists and antagonists. Methods are also provided for identifying compounds that directly interfere with the interaction of NRIF3 and TR or RXR. Finally, therapies based on modulation of NRIF3 activity are disclosed.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: April 26, 2011
    Assignee: New York University
    Inventors: Vandana Yajnik, Herbert Samuels, Dangsheng Li
  • Publication number: 20090286252
    Abstract: Nucleic acids encoding NRIF3 are described. Polypeptides having amino acid sequences of NRIF3 proteins are also provided. A method is also provided for isolating and cloning NRIF3 cDNA. NRIF3 is useful in development/implementation of high throughput screens to identify novel thyroid hormone receptor (TR) and retinoid X receptor (RXR) agonists and antagonists. Methods are also provided for identifying compounds that directly interfere with the interaction of NRIF3 and TR or RXR. Finally, therapies based on modulation of NRIF3 activity are disclosed.
    Type: Application
    Filed: June 8, 2009
    Publication date: November 19, 2009
    Applicant: New York University
    Inventors: Vandana Yajnik, Herbert H. Samuels, Dangsheng Li
  • Patent number: 7563868
    Abstract: Nucleic acids encoding NRIF3 are described. Polypeptides having amino acid sequences of NRIF3 proteins are also provided. A method is also provided for isolating and cloning NRIF3 cDNA. NRIF3 is useful in development/implementation of high throughput screens to identify novel thyroid hormone receptor (TR) and retinoid X receptor (RXR) agonists and antagonists. Methods are also provided for identifying compounds that directly interfere with the interaction of NRIF3 and TR or RXR. Finally, therapies based on modulation of NRIF3 activity are disclosed.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: July 21, 2009
    Assignee: New York University
    Inventors: Vandana Yajnik, Herbert H. Samuels, Dangsheng Li
  • Publication number: 20080138796
    Abstract: Nucleic acids encoding NRIF3 are described. Polypeptides having amino acid sequences of NRIF3 proteins are also provided. A method is also provided for isolating and cloning NRIF3 cDNA. NRIF3 is useful in development/implementation of high throughput screens to identify novel thyroid hormone receptor (TR) and retinoid X receptor (RXR) agonists and antagonists. Methods are also provided for identifying compounds that directly interfere with the interaction of NRIF3 and TR or RXR. Finally, therapies based on modulation of NRIF3 activity are disclosed.
    Type: Application
    Filed: May 19, 2003
    Publication date: June 12, 2008
    Inventors: Vandana Yajnik, Herbert Samuels, Dangsheng Li
  • Patent number: 7052843
    Abstract: The present invention relates to a method for detecting the post-translational modification of a target protein by a post translational modifier polypeptide molecule; a method for screening a candidate protein for E3 ligase activity; a method of screening a test compound for the ability to regulate the post-translational modification of a target protein by a post-translational modifier polypeptide molecule; and a method for the large-scale detection of candidate target proteins of post-translational modification by a modifier polypeptide molecule. The present invention also relates to a kit for determining whether a test protein is post-translationally modified by a modifier polypeptide molecule; a kit for screening a test compound for the ability to regulate the post-translational modification of a target protein by a post-translational modifier peptide molecule, and another kit for determining whether a test protein is post-translationally modified by a modifier polypeptide molecule.
    Type: Grant
    Filed: October 8, 2002
    Date of Patent: May 30, 2006
    Assignee: New York University
    Inventors: Dangsheng Li, James Yopp, Jr., Herbert H. Samuels
  • Publication number: 20040067497
    Abstract: The present invention relates to a method for detecting the post-translational modification of a target protein by a post translational modifier polypeptide molecule; a method for screening a candidate protein for E3 ligase activity; a method of screening a test compound for the ability to regulate the post-translational modification of a target protein by a post-translational modifier polypeptide molecule; and a method for the large-scale detection of candidate target proteins of post-translational modification by a modifier polypeptide molecule. The present invention also relates to a kit for determining whether a test protein is post-translationally modified by a modifier polypeptide molecule; a kit for screening a test compound for the ability to regulate the post-translational modification of a target protein by a post-translational modifier peptide molecule, and another kit for determining whether a test protein is post-translationally modified by a modifier polypeptide molecule.
    Type: Application
    Filed: October 8, 2002
    Publication date: April 8, 2004
    Inventors: Dangsheng Li, James Yopp, Herbert H. Samuels
  • Patent number: 6639064
    Abstract: Nucleic acids encoding NRIF3 are described. Polypeptides having amino acid sequences of NRIF3 proteins are also provided. A method is also provided for isolating and cloning NRIF3 cDNA. NRIF3 is useful in development/implementation of high throughput screens to identify novel thyroid hormone receptor (TR) and retinoid X receptor (RXR) agonists and antagonists. Methods are also provided for identifying compounds that directly interfere with the interaction of NRIF3 and TR or RXR. Finally, therapies based on modulation of NRIF3 activity are disclosed.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: October 28, 2003
    Assignee: New York University
    Inventors: Dangsheng Li, Vandana Yajnik, Herbert H. Samuels